San Diego, CA · Founded 2024 · Privately Held (backing)
Operator of a biopharmaceutical company intended to develop and commercialize therapies for autoimmune diseases. Timberlyne Therapeutics is based in San Diego, CA and was founded in 2024. Its last reported valuation was $324 million in Jan 2025. It has raised $180 million.
Last reported valuation
$324.2M
Oct 2026
Priced at
—
Total raised
$180.0M
Last round
—
Cap table — not yet on record
Timberlyne Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Timberlyne Therapeutics with a free account
·Watch Timberlyne Therapeutics: the Monday email on marks, rounds and moves
